Recombinant Human FBXL18 Protein，His

FBXL18 is a member of the F-box protein family, which plays a crucial role in ubiquitin-mediated protein degradation, a vital cellular process that regulates various biological functions, including cell cycle progression, signal transduction, and apoptosis. Recent studies have suggested that FBXL18 may be involved in developmental processes and cancer progression. Researchers have been interested in its role as a substrate adaptor for the SCF (Skp1-Cul1-F-box) ubiquitin ligase complex, potentially regulating the degradation of specific target proteins that influence cell proliferation and differentiation. The protein's expression profile in different tissues and its interaction with other cellular pathways indicate its significance in maintaining cellular homeostasis. Furthermore, aberrant expression of FBXL18 has been linked to several malignancies, making it a potential biomarker for disease progression and a therapeutic target. As such, producing recombinant FBXL18 protein is critical for investigating its structural properties, functional mechanisms, and interactions with other proteins. Understanding FBXL18's biology could elucidate its role in physiological processes and its potential contributions to pathological conditions, paving the way for novel therapeutic strategies. Researchers are currently focusing on characterizing FBXL18's function in various cellular contexts, its regulatory mechanisms, and the implications of its dysregulation in diseases, especially cancer. This comprehensive exploration of FBXL18 could offer insights into innovative treatments that leverage the modulation of ubiquitin-mediated pathways to restore normal cellular functions.